发明授权
- 专利标题： Prodrug of triazolone compound
- 专利标题（中）： 三唑酮化合物的前药
-
申请号： US13695665申请日： 2011-05-18
-
公开(公告)号： US08436009B2公开(公告)日： 2013-05-07
- 发明人: Richard Clark , Fumiyoshi Matsuura , Masanobu Shinoda , Shinsuke Hirota , Kazunobu Kira , Hiroshi Azuma , Atsushi Takemura , So Yasui , Kazutomi Kusano , Masaki Mikamoto , Takao Omae
- 申请人： Richard Clark , Fumiyoshi Matsuura , Masanobu Shinoda , Shinsuke Hirota , Kazunobu Kira , Hiroshi Azuma , Atsushi Takemura , So Yasui , Kazutomi Kusano , Masaki Mikamoto , Takao Omae
- 申请人地址： JP Tokyo
- 专利权人： Eisai R&D Management Co., Ltd.
- 当前专利权人： Eisai R&D Management Co., Ltd.
- 当前专利权人地址： JP Tokyo
- 代理机构： Fish & Richardson P.C.
- 国际申请： PCT/JP2011/061919 WO 20110518
- 国际公布： WO2011/145747 WO 20111124
- 主分类号： A61K31/506
- IPC分类号： A61K31/506 ; C07D239/42
摘要：
By oral administration of a compound represented by the following Formula (I): the blood level of Compound (IV): which has an excellent inhibitory action against blood coagulation factor VIIa and the anticoagulant action, reaches a level sufficient for expression of its pharmacological actions. Therefore, the compound of the present invention is useful as a therapeutic and/or prophylactic agent for diseases caused by thrombus formation.
公开/授权文献
- US20130053563A1 PRODRUG OF TRIAZOLONE COMPOUND 公开/授权日：2013-02-28
信息查询
IPC分类:
